CSIMarket
 


Conmed Corporation  (CNMD)
Other Ticker:  
 

Cumulative Conmed's Total Debt to Equity for Trailing Twelve Months Period

CNMD's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

CNMD Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth 11.89 % 11.15 % 15.93 % -4.7 % -5.08 %
Y / Y Total Debt Growth -7.68 % -2.3 % 5.94 % 48.79 % 54.07 %
Total Debt to Equity for Trailing Twelve Months Period 1.29 1.36 1.4 1.43 1.3
Total Ranking # 1724 # 2493 # 2606 # 2703 # 2972
Seq. Equity Growth 4.77 % 2.05 % 3.69 % 0.93 % 4.08 %
Seq. Total Debt Growth -3.85 % -2.72 % -2.24 % 0.96 % 1.75 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to repayements of liabilities of -3.85% Conmed decreased Total Debt to Equity for Trailing Twelve Months Period in the IV. Quarter to 1.29, above Conmed's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 72 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Conmed. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
CNMD Charts and Quotes
Total Debt to Equity CNMD in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 73
Sector # 204
S&P 500 # 1655


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
1.43 0.61 0
(Mar 31 2023)   (Dec. 30, 2013)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Equipment & Supplies Industry Total Debt to Equity for Trailing Twelve Months Period
Accuray Incorporated  3.47 
Biolase Inc   3.12 
Owens and Minor inc  2.46 
Insulet Corporation  2.43 
Tela Bio Inc   2.41 
Neuropace Inc   2.07 
Polypid Ltd   1.99 
Mimedx Group Inc   1.80 
Delcath Systems Inc   1.74 
Baxter International Inc   1.69 
Minerva Surgical Inc   1.65 
Apollo Endosurgery inc   1.65 
3m Company  1.61 
Bioventus Inc   1.61 
Uphealth Inc   1.60 
Novocure Limited  1.39 
Conmed Corporation  1.31 
P3 Health Partners Inc   1.28 
Cerus Corporation  1.27 
Plus Therapeutics Inc   1.26 
Transmedics Group Inc   1.23 
Artivion Inc   1.10 
Viewray Inc   1.07 
Dexcom Inc   1.03 
Nuvasive Inc  1.03 
Neuronetics inc   0.95 
Haemonetics Corporation  0.92 
Pear Therapeutics Inc   0.90 
Integra Lifesciences Holdings Corp  0.83 
Carlisle Companies Incorporated  0.83 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com